154 related articles for article (PubMed ID: 15627815)
1. Erythropoietin on a tightrope: balancing neuronal and vascular protection between intrinsic and extrinsic pathways.
Li F; Chong ZZ; Maiese K
Neurosignals; 2004; 13(6):265-89. PubMed ID: 15627815
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin in the brain: can the promise to protect be fulfilled?
Maiese K; Li F; Chong ZZ
Trends Pharmacol Sci; 2004 Nov; 25(11):577-83. PubMed ID: 15491780
[TBL] [Abstract][Full Text] [Related]
3. [Mechanisms of protective action of erythropoietin in cells].
Borysewicz-Sańczyk H; Szczepański M
Pol Merkur Lekarski; 2011 Jan; 30(175):56-61. PubMed ID: 21542247
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1, 3, and 8.
Chong ZZ; Lin SH; Kang JQ; Maiese K
J Neurosci Res; 2003 Mar; 71(5):659-69. PubMed ID: 12584724
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2.
Kilic U; Kilic E; Soliz J; Bassetti CI; Gassmann M; Hermann DM
FASEB J; 2005 Feb; 19(2):249-51. PubMed ID: 15556972
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin as a novel neuroprotectant.
Genc S; Koroglu TF; Genc K
Restor Neurol Neurosci; 2004; 22(2):105-19. PubMed ID: 15272145
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase-mediated pathways.
Chong ZZ; Kang JQ; Maiese K
Br J Pharmacol; 2003 Mar; 138(6):1107-18. PubMed ID: 12684267
[TBL] [Abstract][Full Text] [Related]
8. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin: cytoprotection in vascular and neuronal cells.
Chong ZZ; Kang JQ; Maiese K
Curr Drug Targets Cardiovasc Haematol Disord; 2003 Jun; 3(2):141-54. PubMed ID: 12769640
[TBL] [Abstract][Full Text] [Related]
10. Cellular protection by erythropoietin: new therapeutic implications?
Joyeux-Faure M
J Pharmacol Exp Ther; 2007 Dec; 323(3):759-62. PubMed ID: 17717190
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin 2nd cerebral protection after acute injuries: a double-edged sword?
Velly L; Pellegrini L; Guillet B; Bruder N; Pisano P
Pharmacol Ther; 2010 Dec; 128(3):445-59. PubMed ID: 20732352
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin and the nervous system.
Genc S; Koroglu TF; Genc K
Brain Res; 2004 Mar; 1000(1-2):19-31. PubMed ID: 15053948
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin and treatment of non-anemic conditions--cardiovascular protection.
Fliser D; Haller H
Semin Hematol; 2007 Jul; 44(3):212-7. PubMed ID: 17631185
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin: a hormone with multiple functions.
Lombardero M; Kovacs K; Scheithauer BW
Pathobiology; 2011; 78(1):41-53. PubMed ID: 21474975
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis and plasticity: role of erythropoietin in vascular systems.
Chong ZZ; Kang JQ; Maiese K
J Hematother Stem Cell Res; 2002 Dec; 11(6):863-71. PubMed ID: 12590701
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line.
Shi Z; Hodges VM; Dunlop EA; Percy MJ; Maxwell AP; El-Tanani M; Lappin TR
Mol Cancer Res; 2010 Apr; 8(4):615-26. PubMed ID: 20353997
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin as an antiapoptotic, tissue-protective cytokine.
Ghezzi P; Brines M
Cell Death Differ; 2004 Jul; 11 Suppl 1():S37-44. PubMed ID: 15243580
[TBL] [Abstract][Full Text] [Related]
18. Does erythropoietin have a dark side? Epo signaling and cancer cells.
Sytkowski AJ
Sci STKE; 2007 Jul; 2007(395):pe38. PubMed ID: 17636183
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective properties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia/ischemia.
van der Kooij MA; Groenendaal F; Kavelaars A; Heijnen CJ; van Bel F
Brain Res Rev; 2008 Nov; 59(1):22-33. PubMed ID: 18514916
[TBL] [Abstract][Full Text] [Related]
20. β Common receptor integrates the erythropoietin signaling in activation of endothelial nitric oxide synthase.
Su KH; Shyue SK; Kou YR; Ching LC; Chiang AN; Yu YB; Chen CY; Pan CC; Lee TS
J Cell Physiol; 2011 Dec; 226(12):3330-9. PubMed ID: 21321940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
